APA (7th ed.) Citation

H, T., M, O., H, T., H, H., M, O., S, N., . . . K, F. (2024). Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis. Inflammation and regeneration, 44(1), 29. https://doi.org/10.1186/s41232-024-00337-2

Chicago Style (17th ed.) Citation

H, Tsuchiya, et al. "Epigenetic Targets of Janus Kinase Inhibitors Are Linked to Genetic Risks of Rheumatoid Arthritis." Inflammation and Regeneration 44, no. 1 (2024): 29. https://doi.org/10.1186/s41232-024-00337-2.

MLA (9th ed.) Citation

H, Tsuchiya, et al. "Epigenetic Targets of Janus Kinase Inhibitors Are Linked to Genetic Risks of Rheumatoid Arthritis." Inflammation and Regeneration, vol. 44, no. 1, 2024, p. 29, https://doi.org/10.1186/s41232-024-00337-2.